Big Molecule Watch

ID: 1b83e026-2619-30fb-68c4

/

Claimed Record

/

Organization: Goodwin Procter

That’s a Wrap – Biosimilars Guide Webinar Series

Big Molecule Watch · January 28, 2021

Recent Biosimilars Deals

Big Molecule Watch · January 23, 2021

Everest Medicines Announces Approval of Clinical Trial Application by China National Medical Products Administration for Phase 3 Registration Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer

Big Molecule Watch · January 20, 2021

Upcoming Webinar – An Overview of the Biosimilars Market in China

Big Molecule Watch · January 19, 2021

FDA Defers Decision on Bevacizumab Biosimilar

Big Molecule Watch · January 13, 2021

Practice Areas

Intellectual Property

Jurisdictions